10-Q Filing

SUPERNUS PHARMACEUTICALS, INC. CIK: 1356576 Q2 2015

Filing Information

Form Type	10-Q
Accession Number	`0001104659-15-057341`
Period End Date	20150630
Filing Date	20150807
Fiscal Year	2015
Fiscal Period	Q2
XBRL Instance	supn-20150630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 80 Cash Flow Statement 64 Comprehensive Income 14

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	130.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	130.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$32.98M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	48.44M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	42.97M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$36.40M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.96M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$33.11M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	42.97M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$36.68M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$37.94M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	48.44M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$17.27M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$17.90M	USD	Point-in-time
Inventories, net	`InventoryNet`	$13.44M	USD	Point-in-time
Inventories, net	`InventoryNet`	$13.59M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.85M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.46M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$105.74M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$108.89M	USD	Point-in-time
Long term marketable securities	`MarketableSecuritiesNoncurrent`	$19.82M	USD	Point-in-time
Long term marketable securities	`MarketableSecuritiesNoncurrent`	$33.49M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.45M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.91M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.43M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$11.60M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$918.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$435.00K	USD	Point-in-time
Total assets	`Assets`	$137.51M	USD	Point-in-time
Total assets	`Assets`	$154.17M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.52M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.86M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$31.75M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$25.49M	USD	Point-in-time
Deferred licensing revenue	`DeferredRevenueLicensingCurrent`	$143.00K	USD	Point-in-time
Deferred licensing revenue	`DeferredRevenueLicensingCurrent`	$143.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$36.41M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$27.49M	USD	Point-in-time
Deferred licensing revenue, net of current portion	`DeferredRevenueLicensingNoncurrent`	$1.27M	USD	Point-in-time
Deferred licensing revenue, net of current portion	`DeferredRevenueLicensingNoncurrent`	$1.20M	USD	Point-in-time
Convertible notes, net of discount	`ConvertibleLongTermNotesPayable`	$8.76M	USD	Point-in-time
Convertible notes, net of discount	`ConvertibleLongTermNotesPayable`	$26.95M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$3.35M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$3.88M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	$6.56M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	$2.07M	USD	Point-in-time
Total liabilities	`Liabilities`	$66.15M	USD	Point-in-time
Total liabilities	`Liabilities`	$51.80M	USD	Point-in-time
Common stock, $0.001 par value, 130,000,000 shares authorized at June 30, 2015 and December 31, 2014; 48,444,821 and 42,974,463 shares issued and outstanding at June 30, 2015 and December 31, 2014, respectively	`CommonStockValue`	$43.00K	USD	Point-in-time
Common stock, $0.001 par value, 130,000,000 shares authorized at June 30, 2015 and December 31, 2014; 48,444,821 and 42,974,463 shares issued and outstanding at June 30, 2015 and December 31, 2014, respectively	`CommonStockValue`	$48.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$230.12M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$258.20M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-151.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-154.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-155.73M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-158.66M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$102.36M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$71.35M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$137.51M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$154.17M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net product sales	`SalesRevenueNet`	$34.27M	USD	1 Quarter
Net product sales	`SalesRevenueNet`	$36.60M	USD	2 Qtrs
Net product sales	`SalesRevenueNet`	$62.36M	USD	2 Qtrs
Net product sales	`SalesRevenueNet`	$27.61M	USD	1 Quarter
Licensing revenue	`LicensesRevenue`	$2.15M	USD	2 Qtrs
Licensing revenue	`LicensesRevenue`	$822.00K	USD	2 Qtrs
Licensing revenue	`LicensesRevenue`	$786.00K	USD	1 Quarter
Licensing revenue	`LicensesRevenue`	$2.07M	USD	1 Quarter
Total revenue	`Revenues`	$38.76M	USD	2 Qtrs
Total revenue	`Revenues`	$29.68M	USD	1 Quarter
Total revenue	`Revenues`	$63.19M	USD	2 Qtrs
Total revenue	`Revenues`	$35.05M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$3.38M	USD	2 Qtrs
Cost of product sales	`CostOfGoodsSold`	$2.15M	USD	2 Qtrs
Cost of product sales	`CostOfGoodsSold`	$1.66M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$1.76M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$10.56M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.68M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$6.88M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$9.16M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$19.58M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$42.74M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$23.34M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$37.11M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$31.98M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$25.92M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$48.42M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$56.68M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$6.51M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-9.67M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$3.08M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$3.76M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$85.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$250.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$187.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$137.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.28M	USD	1 Quarter
Interest expense	`InterestExpense`	$331.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$712.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$2.48M	USD	2 Qtrs
Changes in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$1.00K	USD	1 Quarter
Changes in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$1.35M	USD	2 Qtrs
Changes in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$-48.00K	USD	2 Qtrs
Changes in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$678.00K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.73M	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.38M	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-39.00K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-241.00K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$25.00K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$25.00K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-409.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-2.67M	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-554.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-2.86M	USD	2 Qtrs
Earnings (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-12.34M	USD	2 Qtrs
Earnings (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.67M	USD	1 Quarter
Earnings (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.65M	USD	2 Qtrs
Earnings (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.20M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$724.00K	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$662.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$2.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$3.20M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$2.92M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-12.34M	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.06	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.08	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.30	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.04	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.03	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.06	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.08	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.30	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	41.60M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	42.06M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	47.91M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	46.25M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	47.69M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	52.27M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	41.60M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	42.37M	shares	1 Quarter

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$2.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$3.20M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$2.92M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-12.34M	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.73M	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.38M	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-39.00K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-241.00K	USD	1 Quarter
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	$1.35M	USD	2 Qtrs
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	$-48.00K	USD	2 Qtrs
Unrealized gain on marketable securities	`MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments`	$-3.00K	USD	2 Qtrs
Unrealized gain on marketable securities	`MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments`	$-1.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$431.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$460.00K	USD	2 Qtrs
Amortization of deferred financing costs and debt discount	`AmortizationOfFinancingCostsAndDiscounts`	$524.00K	USD	2 Qtrs
Amortization of deferred financing costs and debt discount	`AmortizationOfFinancingCostsAndDiscounts`	$1.09M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$1.32M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$2.02M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$630.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$5.80M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$2.95M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$151.00K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$738.00K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.02M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.65M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.33M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$2.06M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$6.27M	USD	2 Qtrs
Deferred product revenue, net	`IncreaseDecreaseInDeferredProductRevenueNet`	$-7.88M	USD	2 Qtrs
Deferred licensing revenue	`IncreaseDecreaseInDeferredLicensingRevenue`	$-133.00K	USD	2 Qtrs
Deferred licensing revenue	`IncreaseDecreaseInDeferredLicensingRevenue`	$-72.00K	USD	2 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$107.00K	USD	2 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-482.00K	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$15.17M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-26.04M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$19.90M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$34.27M	USD	2 Qtrs
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$21.86M	USD	2 Qtrs
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$27.09M	USD	2 Qtrs
Purchases of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$777.00K	USD	2 Qtrs
Purchases of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$381.00K	USD	2 Qtrs
Deferred legal fees	`PaymentsToAcquireIntangibleAssets`	$6.28M	USD	2 Qtrs
Deferred legal fees	`PaymentsToAcquireIntangibleAssets`	$2.04M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$4.77M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-19.47M	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.01M	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$251.00K	USD	2 Qtrs
Cash settlement of debt to equity conversion	`RepaymentsOfConvertibleDebt`	$1.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.01M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$250.00K	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-21.02M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.29M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$32.98M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$36.40M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.96M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$33.11M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$32.98M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$36.40M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.96M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$33.11M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	$1.50M	USD	2 Qtrs
Cash paid for interest	`InterestPaid`	$504.00K	USD	2 Qtrs
Conversion of convertible notes and interest make-whole	`DebtConversionConvertedInstrumentAmount1`	$10.68M	USD	2 Qtrs
Conversion of convertible notes and interest make-whole	`DebtConversionConvertedInstrumentAmount1`	$25.06M	USD	2 Qtrs

Comprehensive Income 14 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$2.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$3.20M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$2.92M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-12.34M	USD	2 Qtrs
Unrealized net (loss) gain on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$3.00K	USD	2 Qtrs
Unrealized net (loss) gain on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-86.00K	USD	1 Quarter
Unrealized net (loss) gain on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$1.00K	USD	2 Qtrs
Other comprehensive (loss) income:	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$3.00K	USD	2 Qtrs
Other comprehensive (loss) income:	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$1.00K	USD	2 Qtrs
Other comprehensive (loss) income:	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-86.00K	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$2.93M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-12.34M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$3.20M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$1.92M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.